结核病的实验诊断技术应用及流程规范化

doi:10.16150/j.1671-2870.2019.02.001

摘要/Abstract

中图分类号:

R715.2

汪峰, 罗颖, 孙自镛. 结核病的实验诊断技术应用及流程规范化[J]. 诊断学理论与实践, 2019, 18(2): 121-126.

参考文献 28

[1]	Kaufmann SH, Parida SK. Tuberculosis in Africa: lear-ning from pathogenesis for biomarker identification[J]. Cell Host Microbe, 2008, 4(3):219-228.
[2]	World Health Organization (WHO). Global tuberculosis report, 2014[R/OL]. WHO, 2014[2018-12-29].https://www.who.int/tb/en/.
[3]	Minion J, Brunet L, Pai M. Fluorescent light emitting diode (LED) microscopy for the detection of Mycobacte-rium tuberculosis: a systematic review & meta-analysis[C/OL]. Geneva, Switzerland: WHO, 2009[2018-12-29].https://www.researchgate.net/publication/237765059_Fluores-cent_Light_Emitting_Diode_LED_Microscopy_for_the_Detection_of_Mycobacterium_tuberculosis_a_Systematic_Review_Meta-analysis
[4]	Dorman S. Advances in the diagnosis of tuberculosis: current status and future prospects[J]. Int J Tuberc Lung Dis, 2015, 19(5):504-516.
[5]	Lewinsohn DM, Leonard MK, LoBue PA, et al. Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children[J]. Clin Infect Dis, 2017, 64(2):111-115.
[6]	Henry D. Isenberg. Clinical Microbiology Procedures Handbook[M]. 4th. America Society for Microbiology, 2007.
[7]	World Health Organization (WHO). Use of liquid TB culture and drug susceptibility testingDST in low and medium income settings: summary report of the expert group meeting on the use of liquid culture media[C]. WHO, 2007.
[8]	Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases[J]. Am J Respir Crit Care Med, 2007, 175(4):367-416.
[9]	World Health Organization(WHO). Implementing tuberculosis diagnostics: A policy framework[R/OL]. WHO, 2015[2018-12-29].https://www.who.int/tb/publications/implementing_TB_diagnostics/en/.
[10]	World Health Organization(WHO). Molecular line probe assays for rapid screening of patients at risk of multidrug-resistant tuberculosis (MDR-TB)[C]. WHO, 2008.
[11]	World Health Organization(WHO). Xpert MTB/RIF implementation manual Technical and operational ‘how-to’: practical considerations[R/OL]. WHO, 2014[2018-12-29].https://www.who.int/tb/publications/xpert_implem_manual/en/.
[12]	World Health Organization (WHO). The use of loop-media-ted isothermal amplification (TB-LAMP) for the diagnosis of pulmonary tuberculosis: policy guidance[R/OL]. WHO, 2016[2018-12-29].https://www.who.int/tb/publications/lamp-diagnosis-molecular/en/.
[13]	World Health Organization (WHO). Definitions and reporting framework for tuberculosis[C]. WHO, 2013.
[14]	WS288-2017肺结核诊断[S]. 中华人民共和国卫生行业标准, 2017.
[15]	World Health Organization( WHO). Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF assay for the diagnosis of pulmonary and extrapulmonary TB in adults and children[C]. WHO, 2013.
[16]	World Health Organization ( WHO). XpertMTB/RIF:WHO Policy Update and Implementation Manual[C]. WHO, 2014.
[17]	Dorman SE, Schumacher SG, Alland D, et al. Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study[J]. Lancet Infect Dis, 2018, 18(1):76-84.
[18]	Bahr NC, Nuwagira E, Evans EE, et al. Diagnostic accuracy of Xpert MTB/RIF Ultra for tuberculous meningitis in HIV-infected adults: a prospective cohort study[J]. Lancet Infect Dis, 2018, 18(1):68-75.
[19]	Lee YM, Kim SM, Park SJ, et al. Indeterminate T-SPOT.TB Test Results in Patients with Suspected Extrapulmonary Tuberculosis in Routine Clinical Practice[J]. Infect Chemother, 2013, 45(1):44-50.
[20]	Latorre I, Carrascosa JM, Vilavella M, et al. Diagnosis of tuberculosis infection by interferon-gamma release assays in patients with psoriasis[J]. J Infect, 2014, 69(6):600-606.
[21]	Lalvani A, Pareek M. Interferon gamma release assays: principles and practice[J]. Enferm Infecc Microbiol Clin, 2010, 28(4):245-252.
[22]	Ling DI, Pai M, Davids V, et al. Are interferon-γ release assays useful for diagnosing active tuberculosis in a high-burden setting?[J]. Eur Respir J, 2011, 38(3):649-656.
[23]	Wang F, Hou HY, Wu SJ, et al. Using the TBAg/PHA ratio in the T-SPOT(?).TB assay to distinguish TB disease from LTBI in an endemic area[J]. Int J Tuberc Lung Dis, 2016, 20(4):487-493.
[24]	Bosco MJ, Hou H, Mao L, et al. The performance of the TBAg/PHA ratio in the diagnosis of active TB disease in immunocompromised patients[J]. Int J Infect Dis, 2017, 59:55-60.
[25]	Zhou Y, Du J, Hou HY, et al. Application of ImmunoScore Model for the Differentiation between Active Tuberculosis and Latent Tuberculosis Infection as Well as Monitoring Anti-tuberculosis Therapy[J]. Front Cell Infect Microbiol, 2017, 7:457.
[26]	Wang F, Hou H, Zhou H, et al. Use of TBAg/PHA ratio in distinguishing tuberculoma from cancer in solitary pulmonary nodule or mass[J]. Clin Respir J, 2018, 12(3):1174-1181.
[27]	Wang F, Yu J, Zhou Y, et al. The Use of TB-Specific Antigen/Phytohemagglutinin Ratio for Diagnosis and Treatment Monitoring of Extrapulmonary Tuberculosis[J]. Front Immunol, 2018, 9:1047.
[28]	Wu X, Huang H, Hou H, et al. Diagnostic Performance of a 5-Marker Predictive Model for Differential Diagnosis Between Intestinal Tuberculosis and Crohn's Disease[J]. Inflamm Bowel Dis, 2018, 24(11):2452-2460.

结核病的实验诊断技术应用及流程规范化

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 28

相关文章 15

编辑推荐

Metrics

本文评价

[1]	何亲羽, 王伟, 陈立芬, 张雪蕾, 董治亚. LHCGR基因突变致家族性男性性早熟2例报告及文献复习[J]. 诊断学理论与实践, 2022, 21(05): 598-605.
[2]	陈志敏, 何浩岚. 艾滋病合并马尔尼菲篮状菌病的诊治现状[J]. 诊断学理论与实践, 2022, 21(04): 425-430.
[3]	沈银忠. 《人类免疫缺陷病毒感染/艾滋病合并结核分枝杆菌感染诊治专家共识》解读[J]. 诊断学理论与实践, 2022, 21(04): 431-436.
[4]	陈宏, 沈银忠. 人类免疫缺陷病毒感染/艾滋病合并结核病的诊治进展[J]. 诊断学理论与实践, 2022, 21(04): 530-534.
[5]	何新, 陈慧, 冯炜炜. 机器学习算法在辅助超声诊断附件肿块良恶性中的应用研究进展[J]. 诊断学理论与实践, 2022, 21(04): 541-546.
[6]	徐子真, 李擎天, 刘湘帆, 李莉, 李惠, 王也飞, 吴洁敏, 陈宁, 梁璆荔, 陈松立, 戴健敏, 宋珍, 丁磊. 实验诊断学在线课程的建立和实践[J]. 诊断学理论与实践, 2022, 21(04): 547-550.
[7]	赵然, 詹维伟, 侯怡卿. 计算机辅助诊断系统辅助超声诊断甲状腺弥漫性病变合并结节良恶性的应用价值[J]. 诊断学理论与实践, 2022, 21(03): 390-394.
[8]	郭业兵, 郑金峰. 阴道壁胃肠道外间质瘤一例报道并文献复习[J]. 诊断学理论与实践, 2022, 21(03): 405-407.
[9]	王刚, 陈生弟. 神经病学的诊断：起源、发展及挑战[J]. 诊断学理论与实践, 2022, 21(01): 1-4.
[10]	唐静仪, 余群, 刘军. 结合人工智能的结构影像分析对阿尔茨海默病的早期预测及精准诊断研究进展[J]. 诊断学理论与实践, 2022, 21(01): 12-17.
[11]	魏文石. 直面我国阿尔茨海默病诊治的挑战——《中国阿尔茨海默病报告2021》解读[J]. 诊断学理论与实践, 2022, 21(01): 5-7.
[12]	王蔚, 王小钦. 缺铁性贫血的病因诊断[J]. 诊断学理论与实践, 2021, 20(06): 529-532.
[13]	岳婧婧, 宋琦, 江旭峰, 王黎, 赵维莅, 严福华. 磁共振全身扩散加权成像结合T2WI抑脂序列与FDG-PET/CT在初发淋巴瘤分期及病灶检出的对比研究[J]. 诊断学理论与实践, 2021, 20(06): 540-546.
[14]	王昭晖, 吴海波. 胃神经鞘瘤31例临床病理学分析[J]. 诊断学理论与实践, 2021, 20(06): 552-556.
[15]	王广宇, 杨昕, 张立娟, 谭姣容. 住院新诊断2型糖尿病男性患者血浆总睾酮水平与骨钙素的相关性研究[J]. 诊断学理论与实践, 2021, 20(06): 573-578.